In evaluating feasibility of delivering intensive cancer therapy Tenenbaum et al. evaluated the use of supportive measures including iron, erythropoietin, IL‐11, G‐CSF, and stem cell rescue in 14 pediatric oncology patients of JW faith.5 The gene discussed is EPO; the disease is cancer.